PainReform Ltd. Joins NVIDIA Connect Program
Ticker: PRFX · Form: 6-K · Filed: Aug 19, 2025 · CIK: 1801834
| Field | Detail |
|---|---|
| Company | Painreform Ltd. (PRFX) |
| Form Type | 6-K |
| Filed Date | Aug 19, 2025 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | bullish |
Sentiment: bullish
Topics: partnership, technology, press-release
Related Tickers: NVDA
TL;DR
PainReform accepted into NVIDIA Connect Program with DeepSolar, expect tech boost.
AI Summary
On August 19, 2025, PainReform Ltd. announced its acceptance into the NVIDIA Connect Program, a collaboration with DeepSolar. This program aims to leverage NVIDIA's technology for advancements in PainReform's solutions.
Why It Matters
Inclusion in the NVIDIA Connect Program suggests PainReform will gain access to advanced technology and expertise, potentially accelerating product development and innovation in the pain management sector.
Risk Assessment
Risk Level: medium — While acceptance into a program with a major tech company like NVIDIA is positive, the actual impact on PainReform's business and financial performance is yet to be determined.
Key Players & Entities
- PainReform Ltd. (company) — Registrant and subject of the press release.
- NVIDIA Connect Program (company) — Program PainReform has been accepted into.
- DeepSolar (company) — Collaborator with PainReform in the NVIDIA Connect Program.
- August 19, 2025 (date) — Date of the press release announcing the program acceptance.
FAQ
What is the primary benefit PainReform expects from joining the NVIDIA Connect Program?
The filing indicates the program aims to leverage NVIDIA's technology for advancements in PainReform's solutions, suggesting improved technology and innovation.
Who is PainReform collaborating with within the NVIDIA Connect Program?
PainReform is collaborating with DeepSolar as part of its acceptance into the NVIDIA Connect Program.
When was the press release announcing this news filed?
The press release was issued on August 19, 2025, and is attached as Exhibit 99.1 to this 6-K filing.
What type of company is PainReform Ltd. based on its SIC code?
PainReform Ltd. is classified under Pharmaceutical Preparations (SIC code 2834).
What is the principal executive office location for PainReform Ltd.?
The principal executive offices are located at 65 Yigal Alon St., Tel Aviv 6744316, Israel.
Filing Stats: 183 words · 1 min read · ~1 pages · Grade level 9.5 · Accepted 2025-08-19 08:45:37
Filing Documents
- zk2533641.htm (6-K) — 9KB
- exhibit_99-1.htm (EX-99.1) — 15KB
- image0.jpg (GRAPHIC) — 367KB
- 0001178913-25-002981.txt ( ) — 530KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: August 19, 2025 PAINREFORM LTD. By: /s/ Ehud Geller Ehud Geller Executive Chairman of the Board and Interim Chief Executive Officer